Indonesia expects halal certificate for experimental vaccine
by Edna Tarigan
Indonesia's highest Muslim clerical body is expected to issue a halal certification for the experimental COVID-19 vaccine developed by China-based Sinovac Biotech, officials said Monday.
The certification would be a significant step in immunization efforts in the world's most populous Muslim-majority country, should the vaccine be approved for use.
"A study by the Indonesian Ulema Council Halal Product Guarantee Agency and Institute for the Assessment of Food, Drugs and Cosmetics has been completed and has been submitted to the council for the making of a fatwa and halal certification," Human Development and Culture Minister Muhadjir Effendy said at a news conference.
Over 1 million doses of the experimental COVID-19 vaccine developed by Sinovac arrived in Indonesia on Sunday evening. The government has no exact schedule for distributing the doses.
Health Minister Terawan Agus Putranto said Monday that the experimental vaccine needs to successfully complete phase-three clinical trials before it can be distributed in Indonesia.
"The government will provide a vaccine that is proven safe and passes clinical trials under World Health Organization recommendations," Putranto said.
Hermawan Saputra of the Indonesian Public Health Expert Association said the 1.2 million doses are only enough for an initial group of 600,000 people, since each person must receive two doses. "It does not really have significant meaning. The government should guarantee that there will be enough to for distribution to the entire country," Saputra said.
Saputra said that if the experimental vaccine passes the third-phase clinical trials, immunization programs are expected to begin in the middle of next year.
The government has announced that it plans to use vaccines from several different producers in its effort to vaccinate the world's fourth most populated country. So far, the Sinovac candidate vaccine is the only one to arrive in the country.
Monday, the Health Ministry announced 5,754 new COVID-19 cases, bringing the confirmed total to 581,550, including 17,867 deaths, the highest in Southeast Asia.
Let us know if there is a problem with our content
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page.
For general inquiries, please use our contact form.
For general feedback, use the public comments section below (please adhere to guidelines).
Thank you for taking time to provide your feedback to the editors
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Donate and enjoy an ad-free experience
We keep our content available to everyone.
Consider supporting Science X's mission by getting a premium account.
This article has been reviewed according to Science X's editorial process
and policies.
Editors
have highlighted the following attributes while ensuring the content's credibility:
Medical Xpress is a web-based medical and health news service that is part of the renowned Science X network.
Based on the years of experience as a Phys.org medical research channel, started in April 2011, Medical Xpress became a separate website.
Medical Xpress is a part of Science X network.
With global reach of over 5 million monthly readers and featuring dedicated websites for hard sciences, technology, smedical research and health news,
the Science X network is one of the largest online communities for science-minded people.